Milea Timbergen

193 Table 1. Clinical characteristics of the total cohort and of individual patient data of included studies Total n=329 Kim et al. (n = 49) 43 Salas et al. (n = 39) 49 Nishida et al. 42 (n = 3) Mullen et al. 20 (n = 63) Mussi et al. 41 (n = 17) Van Broekhoven et al. 22 (n = 47) Colombo et al. 23 (n = 111) Sex Male 82 (24.9%) 18 (36.7%) 8 (20.5%) 1 (33.3%) 13 (20.6%) 2 (11.8%) 13 (27.7%) 27 (24.3%) Female 247 (75.1%) 31 (63.3%) 31 (79.5%) 2 (66.7%) 50 (79.4%) 15 (88.2%) 34 (72.3%) 84 (75.7%) Tumour Site Trunk / back 194 (59%) 28 (57.1%) 23 (59%) 3 (100%) 29 (46%) 17 (100 %) 32 (68.1%) 62 (55.9%) Head / neck 9 (2.7%) 1 (2%) 4 (10.3%) 0 1 (1.6%) 0 3 (6.4%) 0 Extremity 77 (23.4%) 20 (40.8%) 12 (30.8%) 0 33 (52.4%) 0 12 (25.5%) 0 EA NS 49 (14.9%) 0 0 0 0 0 0 49 (44.1%) Mean age in years (SD) 41 (14.3) 40 (13.1) 47 (16.5) 35 (10) 38 (13.6) 37 (7.3) 39 (12.7) 43 (15.2) Median age in years (IQR) 38 (31-50) 37 (29-49) 46 (36-60) 36 (25-45) a 36 (27-46) 36 (33.5-39) 38 (30-46) 38 (32-54) Age in years ≤30 years 81 (24.6%) 13 (26.5%) 9 (23.1%) 1 (33.3%) 22 (34.9%) 2 (11.8%) 12 (25.5%) 22 (19.8%) 31>38 years 79 (24%) 13 (26.5%) 2 (5.1%) 1 (33.3%) 13 (20.6%) 9 (52.9%) 11 (23.4%) 30 (27%) ≥38<50 years 78 (23.7%) 10 (20.4%) 9 (23.1%) 1 (33.3%) 17 (27%) 5 (29.4%) 16 (34%) 20 (18%) ≥ 50 years 91 (27.7%) 13 (26.5%) 19 (48.7%) 0 11 (17.5%) 1 (5.9%) 8 (17%) 39 (65.1%) Mean tumour size in mm (SD) 67 (44 ) 77.9 (45.5) 74.5 (52) 48.3 (2.9) 71.8 (38.5) 44.2 (33.3) 40.7 (31.4) 70.9 (46.2) Median tumour size in mm (IQR) 55 (36.8-90) 70 (42.5-110) 65 (40-95) 50 (45-50) a 70 (40-95) 26 (19-66.5) 35 (23-45) 60 (40-90) 7